Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v2.4.1.9
Consolidated Balance Sheets (USD $)
Sep. 30, 2013
Dec. 31, 2012
ASSETS    
Cash and cash equivalents $ 0us-gaap_CashAndCashEquivalentsAtCarryingValue $ 123,000us-gaap_CashAndCashEquivalentsAtCarryingValue
Inventories 40,000us-gaap_InventoryNet 59,000us-gaap_InventoryNet
Prepaid expenses 0us-gaap_PrepaidExpenseCurrent 20,000us-gaap_PrepaidExpenseCurrent
Total Current Assets 40,000us-gaap_AssetsCurrent 202,000us-gaap_AssetsCurrent
Patents, net 22,000us-gaap_FiniteLivedIntangibleAssetsNet 24,000us-gaap_FiniteLivedIntangibleAssetsNet
Total Other Assets 22,000us-gaap_AssetsNoncurrent 24,000us-gaap_AssetsNoncurrent
TOTAL ASSETS 62,000us-gaap_Assets 226,000us-gaap_Assets
Current Liabilities:    
Bank overdraft 1,000us-gaap_BankOverdrafts 0us-gaap_BankOverdrafts
Accounts payable 935,000us-gaap_AccountsPayableCurrent 878,000us-gaap_AccountsPayableCurrent
Accrued interest 1,542,000us-gaap_InterestPayableCurrent 1,253,000us-gaap_InterestPayableCurrent
Accrued expenses 1,271,000us-gaap_AccruedLiabilitiesCurrent 1,173,000us-gaap_AccruedLiabilitiesCurrent
Line of credit 0us-gaap_LineOfCredit 27,000us-gaap_LineOfCredit
Warrant liability 13,000us-gaap_ProductWarrantyAccrualClassifiedCurrent 1,378,000us-gaap_ProductWarrantyAccrualClassifiedCurrent
Settlement note payable 695,000OXIS_SettlementNotePayable 702,000OXIS_SettlementNotePayable
Demand notes payable 63,000OXIS_DemandNotesPayableNetOfDiscountOf54000And0 63,000OXIS_DemandNotesPayableNetOfDiscountOf54000And0
Convertible debentures, net of discount of $244,000 and $809,000 964,000OXIS_ConvertibleDebenturesNetOfDiscountOf0And0CurrentPortion 463,000OXIS_ConvertibleDebenturesNetOfDiscountOf0And0CurrentPortion
Convertible debentures 547,000us-gaap_ConvertibleDebtCurrent 625,000us-gaap_ConvertibleDebtCurrent
Total Current Liabilities 6,031,000us-gaap_LiabilitiesCurrent 6,562,000us-gaap_LiabilitiesCurrent
Stockholders' Deficit:    
Convertible preferred stock - $0.001 par value; 15,000,000 shares authorized: Series C - 96,230 and 96,230 shares issued and outstanding at September 30, 2013 and December 31, 2012, respectively 1,000OXIS_ConvertiblePreferredStockSeriesC 1,000OXIS_ConvertiblePreferredStockSeriesC
Series H - 25,000 and 25,000 shares issued and outstanding at September 30, 2013 and December 31, 2012, respectively 0OXIS_ConvertiblePreferredStockSeriesH 0OXIS_ConvertiblePreferredStockSeriesH
Series I - 1,666,667 and 1,666,667 shares issued and outstanding at September 30, 2013 and December 31, 2012, respectively 2,000OXIS_ConvertiblePreferredStockSeriesI 2,000OXIS_ConvertiblePreferredStockSeriesI
Common stock - $0.001 par value; 600,000,000 shares authorized; 573,051,524 and 500,573,746 shares issued and outstanding at September 30, 2013 and December 31, 2012, respectively 573,000us-gaap_CommonStockValue 501,000us-gaap_CommonStockValue
Additional paid-in capital 82,709,000us-gaap_AdditionalPaidInCapital 82,216,000us-gaap_AdditionalPaidInCapital
Accumulated deficit (89,113,000)us-gaap_RetainedEarningsAccumulatedDeficit (88,966,000)us-gaap_RetainedEarningsAccumulatedDeficit
Noncontrolling interest (141,000)us-gaap_MinorityInterest (90,000)us-gaap_MinorityInterest
Total Stockholders' Deficit (5,969,000)us-gaap_StockholdersEquity (6,336,000)us-gaap_StockholdersEquity
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT $ 62,000us-gaap_LiabilitiesAndStockholdersEquity $ 226,000us-gaap_LiabilitiesAndStockholdersEquity